Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 21 INDUSTRY 9 NIH 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Prostatic Hyperplasia 1

Interventions

Cisplatin 49 Capecitabine 42 Radiotherapy 33 Oxaliplatin 33 Gemcitabine 33 apatinib 32 Cyclophosphamide 32 Drug Therapy 31 Paclitaxel 30 Carboplatin 29 tislelizumab 27 Irinotecan 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 Surgical Procedures, Operative 20 Nivolumab 19 pembrolizumab 18 fludarabine 18 Metformin 16 Exercise 16 Radiation 15 camrelizumab 14 S 1 (combination) 14 Control Groups 14 Blood Specimen Collection 14 Pemetrexed 13 Standard of Care 12 anlotinib 11 Neoadjuvant Therapy 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Dutasteride × Clear all

NCT06001619 2023-08-21

PROMED

Turku University Hospital

Phase 4 Recruiting

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡